Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Holding TSE:CRDL?
Track your performance easily

Cardiol Therapeutics (CRDL) Income Statement

143 Followers

Cardiol Therapeutics Income Statement

Last quarter (Q ), Cardiol Therapeutics's total revenue was C$―, a decrease of ― from the same quarter last year. In Q, Cardiol Therapeutics's net income was C$-7.64M. See Cardiol Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
---C$ 78.76K--
Cost of Revenue
------
Gross Profit
------
Operating Expense
C$ 29.79MC$ 29.79MC$ 41.34MC$ 38.74MC$ 20.69MC$ 14.13M
Operating Income
C$ -29.79MC$ -29.79MC$ -41.34MC$ -38.66MC$ -20.69MC$ -14.13M
Net Non Operating Interest Income Expense
C$ 2.04MC$ 2.04MC$ 1.24MC$ -106.00KC$ -76.58KC$ -244.80K
Other Income Expense
C$ -331.46KC$ -331.46KC$ -6.41MC$ 6.92MC$ -27.06KC$ 198.94K
Pretax Income
C$ -28.13MC$ -28.13MC$ -36.45MC$ -31.64MC$ -20.64MC$ -13.68M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -28.13MC$ -28.13MC$ -36.45MC$ -31.64MC$ -20.64MC$ -13.68M
Basic EPS
C$ -0.44C$ -0.44C$ -0.49C$ -0.73C$ -0.69C$ -0.53
Diluted EPS
C$ -0.44C$ -0.44C$ -0.49C$ -0.73C$ -0.69C$ -0.53
Basic Average Shares
C$ 257.85MC$ 64.46MC$ 62.51MC$ 43.22MC$ 29.86MC$ 25.82M
Diluted Average Shares
C$ 257.85MC$ 64.46MC$ 62.51MC$ 43.22MC$ 29.86MC$ 25.82M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
---C$ -38.74MC$ -20.69MC$ -14.13M
Net Income From Continuing And Discontinued Operation
C$ -28.13MC$ -28.13MC$ -36.45MC$ -31.64MC$ -20.64MC$ -13.68M
Normalized Income
C$ -20.67MC$ -20.67MC$ -26.79MC$ -23.25MC$ -15.17MC$ -10.06M
Interest Expense
------
EBIT
C$ -28.13MC$ -28.13MC$ -36.45MC$ -31.64MC$ -20.64MC$ -13.68M
EBITDA
C$ -27.88MC$ -27.88MC$ -36.23MC$ -38.44MC$ -20.46MC$ -13.53M
Currency in CAD

Cardiol Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis